TriSalus Life Sciences, Inc. (TLSI) Insider Trading

TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.

Showing latest transactions and SEC Form 4 filings for TLSI.

6 results.

X Filing Date Trade Date Ticker Company Name Insider Name Title Trade Type Price Qty Owned ΔOwn Value
2026-11-17 16:02:11 2026-11-16 TLSI TriSalus Life Sciences, Inc. Marshak Richard Chief Commercial Officer S - Sale $2.43 -544 127,450 -0% -$1,322
2026-11-16 08:16:32 2026-11-12 TLSI TriSalus Life Sciences, Inc. Wahlstrom Mats Director P - Purchase $2.24 +50,000 3,012,030 +2% +$112,000
2026-10-07 16:02:52 2026-10-05 TLSI TriSalus Life Sciences, Inc. Cox Bryan F. Chief of Research S - Sale $4.39 -296 162,805 -0% -$1,299
2026-10-07 16:02:44 2026-10-05 TLSI TriSalus Life Sciences, Inc. Marshak Richard Chief Commercial Officer S - Sale $4.39 -325 127,994 -0% -$1,427
2026-10-07 16:02:37 2026-10-05 TLSI TriSalus Life Sciences, Inc. Stevens Jennifer Chief Regulatory Officer S - Sale $4.39 -316 123,794 -0% -$1,387
2026-10-07 16:02:29 2026-10-05 TLSI TriSalus Life Sciences, Inc. Szela Mary T CEO and President, Director OTHER $4.38 +2,693 1,074,990 0% +$11,795